6:40PM Exactech beats by $0.06, reports revs in-line; guides Q1 EPS above consensus, revs in-line; guides FY09 EPS above consensus, revs above consensus (EXAC) 12.68 -0.42 : Reports Q4 (Dec) earnings of $0.26 per share, excluding non-recurring items, $0.06 better than the First Call consensus of $0.20; revenues rose 21.8% year/year to $40.3 mln vs the $39.9 mln consensus. Co issues upside EPS guidance for Q1, sees EPS of $0.24-0.26, excluding non-recurring items, vs. $0.20 consensus; sees Q1 revs of $42-45 mln vs. $43.77 mln consensus. Co issues upside guidance for FY09, sees EPS of $1.06-1.14, excluding non-recurring items, vs. $0.97 consensus; sees FY09 revs of $184-194 mln vs. $179.73 mln consensus.
5:06PM Oceaneering Intl reports EPS in-line, revs in-line; guides Q1 EPS below consensus; guides FY09 EPS in-line (OII) 30.49 -0.12 : Reports Q4 (Dec) earnings of $0.93 per share, in-line with the First Call consensus of $0.93; revenues rose 9.2% year/year to $525.7 mln vs the $521.5 mln consensus. Co issues downside guidance for Q1, sees EPS of $0.60-0.70 vs. $0.76 consensus. Co issues in-line guidance for FY09, sees EPS of $3.00-3.60 vs. $3.48 consensus.
5:02PM Baidu.com misses by $0.01, reports revs in-line; guides Q1 revs in-line (BIDU): Reports Q4 (Dec) earnings of $1.31 per share, excluding non-recurring items, $0.01 worse than the First Call consensus of $1.32. Co issues in-line guidance for Q1, sees Q1 revs of $114-117 mln vs. $117.66 mln consensus. The number of active online marketing customers during the fourth quarter was over 197,000, an increase of 1.5% from the previous quarter.
5:02PM NCI Building Sys updates Q1 outlook, sees Q1 EPS loss of $0.40-0.45 per diluted share vs ($0.06) First Call consensus (NCS) 10.39 -0.11 : Co announced today that as a result of the continued economic downturn and rapid decline in steel prices, the aggregate volume of tonnage shipped in the 2009 fiscal first quarter by the Buildings and Components groups was 49% lower than in the Q4 of fiscal 2008. Consequently, overall tonnage volume declined 45% sequentially, compared to the 40% previously expected, and was down 40% compared to last year's first quarter. Historically, seasonal factors have resulted in an approximate 25% decline in first quarter volume compared to fourth quarter levels. Revenues are expected to be ~$260 million for the 2009 first quarter. Margin compression caused by significantly lower-than-expected utilization rates and high inventory costs is expected to result in a net loss for the period in the range of $0.40-0.45 per diluted share vs ($0.06) First Call consensus, exclusive of special charges. Co expects that the margin impact from higher inventory costs will be mitigated by the middle of the second quarter. Additionally, steel prices have stabilized at levels that should promote increased utilization of steel as compared to other traditional building materials. In fact, after declining for seven consecutive months, NCI's Buildings group's backlog stabilized at $302 million in December and January.
4:32PM Nutrisystem misses by $0.04, misses on revs (NTRI) 12.42 -0.48 : Reports Q4 (Dec) earnings of $0.16 per share, excluding a $0.27 impairment loss, $0.04 worse than the First Call consensus of $0.20; revenues fell 16.5% year/year to $114.6 mln vs the $121.1 mln consensus. For Q1 of 2009, the co ests Adjusted EBITDA will be between $19 and $23 mln, not comparable to consensus; co defines Adjusted EBITDA as income from continuing operations excluding non-cash employee compensation, other expense, equity and impairment loss, interest, income taxes and depreciation and amortization. Co says, "Current full year visibility, during a period fraught with consumer uncertainty and rising unemployment countered by the potential impact of various stimulus programs, is very limited. With this lack of visibility, we will not offer full year guidance at this time. However, with the flexibility of our eCommerce model, our expanded product line and the depth and experience of our management team, I remain confident that we will emerge from this period a stronger co."
4:21PM Hewlett-Packard reports EPS in-line, misses on revs; guides Q2 EPS below consensus, revs below consensus; guides FY09 EPS in-line, revs below consensus (HPQ) 34.08 -0.26 : Reports Q1 (Jan) earnings of $0.93 per share, excluding non-recurring items, in-line with the First Call consensus of $0.93; revenues rose 1.1% year/year to $28.8 bln vs the $31.93 bln consensus. Co issues downside guidance for Q2, sees EPS of $0.84-0.85, excluding non-recurring items, vs. $0.89 consensus; sees Q2 revs down 2-3%, equates to $27.4-27.7 bln vs. $30.95 bln consensus. Co issues mixed guidance for FY09, sees EPS of $3.76-3.88 vs. $3.77 consensus; sees FY09 revs down 2-5% year/year, equates to $112.45-117.3 bln vs. $126.52 bln consensus. Revenue grew 11% in the Americas to $12.4 billion. Revenue declined 3% in Europe, the Middle East and Africa and 11% in Asia Pacific to $12.0 billion and $4.4 billion, respectively.
4:19PM Advance Auto beats by $0.14, beats on revs (AAP) 32.63 +0.49 : Reports Q4 (Dec) earnings of $0.51 per share, ex-items, $0.14 better than the First Call consensus of $0.37; revenues rose 8.0% year/year to $1.19 bln vs the $1.15 bln consensus. For 2009, co expects 105 new stores and capex of $180-$200 mln. Also for fiscal 2009, the company assumes that each 1% increase in comparable store sales from the company's fiscal 2008 52 week EPS results of $2.65 adds approximately $0.07 in EPS. In addition, a 10 basis point improvement in operating margin is expected to add approximately $0.03 in EPS.
4:16PM priceline.com beats by $0.24, beats on revs; guides Q1 EPS above consensus, revs above consensus (PCLN) 68.74 -0.13 : Reports Q4 (Dec) earnings of $1.29 per share, excluding non-recurring items, $0.24 better than the First Call consensus of $1.05; revenues rose 21.2% year/year to $406 mln vs the $377.8 mln consensus. Co issuesupside guidance for Q1, sees EPS of $0.85-0.95, excluding non-recurring items, vs. $0.81 consensus; sees Q1 revs growth YoY of 5-10%, which equates to ~$423.3-443.5 mln vs. $412.64 mln consensus.
12:35PM HJ Heinz reaffirms FY09 EPS guidance of $2.87-2.91 vs $2.89 First Call consensus (HNZ) 32.70 -0.30 : Co reaffirms FY09 EPS outlook of $2.87-2.91 vs $2.89 First Call consensus at Annual Consumer Analyst Group. "We expect to deliver Heinz's key financial targets for Fiscal 2009: Organic sales growth (combined volume and net price) of 6%; EPS in a range of $2.87-2.91, a growth rate of 9-11%; and operating free cash flow (cash from operations less capital expenditures net of proceeds from disposal of PP&E) of around $850 mln."
8:49AM Altria reaffirms FY09 EPS will grow to a range of $1.70-$1.75 (vs $1.72 consensus ) (MO) 15.57 : Co reaffirms its FY09 EPS of $1.70-$1.75 (vs $1.72 consensus). This forecast reflects higher tobacco excise taxes, investment spending on U.S. Smokeless Tobacco Company's brands, ongoing cost reduction initiatives, increased pension expenses and no share repurchases.
8:19AM Inverness Medical beats by $0.07, beats on revs (IMA) 25.08 : Reports Q4 (Dec) earnings of $0.66 per share, excluding non-recurring items, $0.07 better than the First Call consensus of $0.59; revenues rose 59.5% year/year to $459.3 mln vs the $451.5 mln consensus. The revenue increase was primarily due to $114.0 mln of incremental revenue provided by their Health Management segment, along with $34.6 mln of incremental revenue contributed by their other recently acquired businesses and organic growth which, on a currency adjusted basis, was approximately 10.7% in their Professional Diagnostics segment.
7:17AM Genpact reports Q4 adjusted EPS of $0.76 (no estimates) vs $0.50 year ago; revs increased 26% y/y to $1.04 bln (G) 8.21 : "Based on our current view of our markets and feedback from our clients, we expect revenue growth of 10% to 15%, from a base of $1.04 billion in 2008, and adjusted operating income margin of 16% to 17%, compared to 17.1% in 2008. We are still very optimistic about the opportunities for Genpact, both with existing clients and potential new ones, but we are taking a cautious approach to the current and anticipated environment."
7:04AM Gentiva Health Svcs beats by $0.04, beats on revs; guides FY09 EPS above consensus, revs in-line (GTIV) 26.82 : Reports Q4 (Dec) earnings of $0.43 per share,$0.04 better than the First Call consensus of $0.39; revenues rose 19.3% year/year to $282.9 mln vs the $273 mln consensus. Co issues guidance for FY09, sees EPS of $1.72-1.80 up from $1.62-1.72 vs. $1.65 consensus; sees FY09 revs of $1.14-1.18 bln - up from 1.12-1.17 bln vs. $1.15 bln consensus. Gentiva's 2009 outlook represents an increase in diluted earnings per share of 20% to 30% when compared with 2008 pro forma financial results, which reflect the Company's performance as if the CareCentrix divestiture had occurred at the beginning of fiscal 2008. The 2009 outlook excludes the impact of special items, restructuring or non-recurring charges and any future acquisitions.
6:40AM Suntech Power misses by $0.01, beats on revs; guides Q1 revs in-line (STP)9.14 : Reports Q4 (Dec) loss of $0.27 per share, excluding non-recurring items, $0.01 worse than the First Call consensus of ($0.26); revenues rose 4.3% year/year to $414.4 mln vs the $379.6 mln consensus. Co issues in-line guidance for Q1, sees Q1 revs of $340-380 mln, assuming an exchange rate of $1.28 US dollars to the Euro in Q109, vs. $370.48 mln consensus. Suntech expects full-year 2009 shipments of more than 800MW. Suntech intends to hold PV cell production capacity at 1GW in 2009 until credit market visibility improves. Suntech expects capital expenditures of approximately $100 mln in 2009. The majority of 2009 capital expenditures will be utilized to retrofit existing production capacity to the high efficiency Pluto technology and the completion of the thin film facility.
No comments:
Post a Comment